Publications and Scientific Articles

Report on the 2017 FCF Scientific Conference

The distinguished Journal of Hepatocellular Carcinoma has published a report on FCF’s 2017 Scientific Conference. The authors are Drs. Ted Kastenhuber, Ghassan Abou-Alfa, and John Craig who coordinated the writing and editing. FCF thanks these doctors for their time and commitment to this article. The report, “Road map for fibrolamellar carcinoma: progress and goals of a diversified approach“, can be viewed here.

Other Articles on Fibrolamellar

OrderDateTopicAuthorsArticle title and link
186
2/2021Case reportMatsumoto, Kikuchi, Hara, Tsunashima, et al. Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
18512/2020Mechanisms, pathwaysLu, Aoto, Weng, Nielsen, et alStructural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma
1849/2020TreatmentsLee, Jin, Ko, Kim, et alHyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers
1838/2020ReviewSamdanci, Akatli, Soylu
Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma
1828/2020TreatmentsLamarca, Frizziero, Fulton, et alFibrolamellar carcinoma: Challenging the challenge
1817/2020GenomicsAbou-Alfa, El Dika, Bowman, Berger, et alMolecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver
1806/2020DiagnosticsDu Toit, AlderaFibrolamellar Carcinoma With Predominantly Pseudoglandular Architecture: A Potential Diagnostic Pitfall
1795/2020TreatmentsGliksberg, O'Grady, KentNovel systemic therapies in hard to treat fibrolamellar hepatocellular carcinoma
1785/2020DiagnosticsChen, de Gonzalez, Fazlollahi, et alIn situ hybridisation for albumin RNA in paediatric liver cancers compared with common immunohistochemical markers
1775/2020Clinical trialEl Dika, Mayer, Abou-Alfa, Capanu, et alA Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT ) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma
1765/2020Case reportLemekhova, Hornuss, Polychronidis, et alClinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
1754/2020Mechanisms, pathwaysDinh, SethupathyHotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities
1743/2020Clinical trialAbou-Alfa, Mayer, Gordan, Venook, et alPhase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
1732/2020ModelingDe Oliviera, HuttenlocherDnaJ-PKAc fusion induces liver inflammation in a zebrafish model of Fibrolamellar Carcinoma
1722/2020DiagnosticsDong, Wang, Mao, Zhang, et alImaging Features of Fibrolamellar Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound
1712/2020Case reportRamai, Ofosu, Lai, Gao, et alFibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study
1701/2020OutcomesAssi, Mukherjee, Macchiorlatti, et alPredictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database
1691/2020DiagnosticsAnysz-Grodzicka, Podgorska, CieszanowskiState-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellular cholangiocarcinoma
1681/2020GenomicsDinh, Sritharan, Smith, et alHotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
16712/2019GenomicsHirsch, Negulescu, Gupta, et alBAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
16611/2019Case reportBalbeur, BrichardDNAJB1‐PRKACA–positive metastatic fibrolamellar carcinoma with unknown primary in a pediatric patient
16511/2019GenomicsVyas, Hechtman, Zhang, Benayed, et alDNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma
16410/2019TargetingJewell, Gibson, Guy, et alSingle-Cell RNA Sequencing Identifies Yes-Associated Protein 1–Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma
1639/2019ModelingDe Oliviera, Huttenlocher, et al DNAJB1-PRKACA fusion induces liver inflammation in zebrafish model of Fibrolamellar Hepatocellular Carcinoma
1629/2019PrognosticsLafaro, Eng, Raoff, Melstrom, et alA prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinom
1619/2019Mechanisms, pathwaysRiehle, Kenerson, Riggle, et alNeurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma
1607/2019Mechanisms, pathwaysKarki, Putra, Kim, Laquaglia, et alMDM4 expression in fibrolamellar hepatocellular carcinoma
1596/2019Case reportBauer, Mogler, Braren, et alProgression after Immunotherapy for Fibrolamellar Carcinoma
1586/2019Case reportChalkrabarti, Tella, Kommalapati, et alClinicopathological features and outcomes of fibrolamellar
hepatocellular carcinoma
1575/2019Case reportCho, Chen, Paludo, Conboy, et alHyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review
1565/2019GenomicsTurnham, Smith, Kenerson, Omar, et alAn acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
1554/2019
OverviewKastenhuber, Ramsey, Sullivan, Sage, et alRoad map for fibrolamellar carcinoma: progress and goals of a diversified approach
1543/2019Mechanisms, pathwaysKim, Gani, Layman. Besharati, et alMultiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
1531/2019GenomicsDinh, Jewell, Kranke, Scott, DiehlMicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma
1521/2019Case reportSuarez, Perez, Garzon, Daza, et alFibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
15111/2018ReviewChaudhari, Khobragade, Bhandare, ShrikhandeManagement of fibrolamellar hepatocellular carcinoma
1509/2018ReviewLin, YangFibrolamellar Carcinoma: A Concise Review
1498/2018Case reportTanaka, Hijioka, Iwaya, Mizuno, et alFibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy
1488/2018Case reportBartlett, Leslie, Gupta, GellerAcquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma
1476/2018RadiologyGaneshan,Szklaruk, Kaseb, Kattan, ElsayesFibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases
1466/2018Case reportShah, Kamboj, ClearyLarge Hepatic Mass in an Adolescent Male
1456/2018PathologyGrahamFibrolamellar Carcinoma What Is New and Why It Matters
1444/2018Case reportInce, Isik, Ozdemir, et alLiving-Donor Liver Transplant for Fibrolamellar Hepatocellular Carcinoma With Hilar Lymph Node Metastasis: A Case Report
1433/2018GenomicsFarber, Lalazar, Simon, Hammond, et alNon coding RNA analysis in fibrolamellar hepatocellular carcinoma
1422/2018RadiologyPalm, Sheng, Mayer, Weiss, et alImaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acidenhanced MR
1412/2018ReviewLalazar, SimonFibrolamellar Carcinoma: Recent advances and unresolved questions on the molecular mechanisms
1402/2018Case reportMafeld, French, Tiniakos, et alFibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resectio
1392/2018Case reportBill, Montani, Blum, Dufour, et alFavorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver
1381/2018GenomicsTomasini, Wang, Simon, et alConformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma
13712/2017TargetingStratakisCyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA ): the expected, the unexpected, and what might be next
13612/2017Case reportHammond, Lalazar, Saltsman, et alIntracranial Metastasis in Fibrolamellar Hepatocellular Carcinoma
13512/2017GenomicsGraham, Lackner, Terracciano, et alFibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion
13411/2017GenomicsKastenhuber, Lalazar, Houlihan, et alDNAJB1–PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
13310/2017RadiologySemelka, Nimojan, Chandana, Ramalho, et alMRI features of primary rare malignancies of the liver: A report from four university centres
1329/2017GenomicsKastenhuber, Lalazar, Houlihan, Tschaharganeh, et alDNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
1319/2017ModelingEngelholm, Riaz, Serra, et alCRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1–Prkaca Gene Fusion is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
1309/2017DiagnosticsGraham, Yeh, Lam-Himlin, Roberts, et alMolecular testing for the clinical diagnosis of fibrolamellar carcinoma
1298/2017TargetingCooney, Wei, RangaswamiCD47 is not Over-Expressed in Fibrolamellar Hepatocellular Carcinoma
1286/2017SEER studyNautsch, Ludwig, Xing, Johnson, KimRacial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer A Surveillance, Epidemiology, and End Results (SEER) Population Study
1275/2017Case reportCiurea, Matei, Stanescu, Lupescu, et alFibrolamellar hepatocellular carcinoma with ovarian metastasis - an unusual presentation
1265/2017GenomicsSorenson, Khanin, Bamboat, Cavnar, et alGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation
1255/2017Case reportAndrade, de Lima, de Faria, VargasTP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
1243/2017PathologyKim, Rhee. Yoo. Alves, et alTumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma
1233/2017Case reportVishnu, Kulkarni, Vidhyalakshmi, et alFibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas
1223/2017GenomicsDinh, Vitucci, Wauthier, Graham, et alComprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
1213/2017ReviewWahab, Hanafy, Nakeeb, AliClinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period)
1203/2017Case reportSurjan, dos Santos, Basseres, Makdissi, MachadoA Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation
1193/2017Case reportGraham, Craig, Jin, Olivera, et alEnvironmental exposures as a risk factor for fibrolamellar carcinoma
1181/2017ReviewGraham, TorbensonFibrolamellar carcinoma: A histologically unique tumor with unique molecular findings
11712/2016Case reportHernandez, Ruiz, TorreDuodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy
11611/2016TreatmentsAtienza, Berger, Mei, Shah, et alLiver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective
11511/2016Case reportAlsina, Franco, Nakshabandi, et alSuccessful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma
1148/2016Case reportDiez, Higueras, Zafra, et alFibrolamellar hepatocellular carcinoma: a rare entity diagnosed by abdominal ultrasound
1137/2016ReviewYamashita, Vauthry, Kaseb, Aloia, et alPrognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma
1125/2016ReviewKassahunContemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments
1115/2016Case reportBernieh, Adams, Liu, Flowers, et alFibrolamellar hepatocellular carcinoma in ascitic fluid: A case report with cytohistological correlation
1104/2016Case reportGriffith, Griffith, Krysiak, Magrini, et alA Genomic Case Study of Mixed Fibrolamellar Hepatocellular Carcinoma
1093/2016Mechanisms, pathwaysRiggle, Riehle, Kenerson, Turnham, et alEnhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
1083/2016ReviewRiggle, Turnham, Scott, Yeung, et alFibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
1073/2016Case reportChapuy, Sahai, Sharma, Zhu, KozyrevaHyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm
1062/2016DiagnosticsSergiHepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer
10512/2015Case reportLimaiem, Bouraoui, Sboui, Lahmar, et alFibrolamellar carcinoma versus scirrhous hepatocellular carcinoma : diagnostic usefulness of CD68
10411/2015SEER studyLau, Mahendraraj, ChamberlainHepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011)
10311/2015SEER studyJernigan, Wima, Hanseman, Hoehn, et alNatural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry
10210/2015ModelingPatmanA model of fibrolamellar carcinoma
10110/2015GenomicsSimon, Freije, Farber, Lalazar, et alTranscriptomic characterization of fibrolamellar hepatocellular carcinoma
10010/2015GenomicsReid, SethupathyThe DNAJB1‐PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas
9910/2015ModelingOikawa, Wauthier, Dinh, Selitsky, et alModel of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
989/2015Case reportVilla, Pannala, Faigel, Haakinson, et alMetastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
978/2015GenomicsGraham, Garcia, Griepp,Barr Fritcher, Kipp, TorbensonFGFR1 and FGFR2 in fibrolamellar carcinoma
968/2015GenomicsMalouf, Tahara, Paradis, Fabre, et alMethylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive feature
955/2015Case reportChagas, Kikuchi, Herman, Alencar, et alClinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
944/2015Case reportAroraFibrolamellar Hepatocellular Carcinoma Presenting as Obstructive Jaundice: Uncommon Presentation of a Rare Entity
934/2015EditorialAndersenFibrolamellar Hepatocellular Carcinoma: A Rare but Distinct Type of Liver Cancer
922/2015GenomicsGraham, Jin, Knutson, Kloft-Nelson, et alDNAJB1-PRKACA is specific for fibrolamellar carcinoma
911/2015GenomicsCornella, Alsinet. Sayols, Zhang, et alUnique genomic profile of fibrolamellar hepatocellular carcinoma
901/2015GenomicsDarcy, Chiaroni-Clarke, Murphy, et alThe genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients
891/2015PrognosticsDarcy, Malek, Kobos, et alPrognostic factors in fibrolamellar hepatocellular carcinoma in young people
8812/2014ReviewLim. Farber, LaQuagliaAdvances in fibrolamellar hepatocellular carcinoma: a review
8712/2014TreatmentsHerman, Chagras, Perini, Coelho, et alSurgical treatment of fibrolamellar hepatocellular carcinoma: an underestimated malignant tumor?
868/2014GenomicsXu, Hazard, Zmoos, Jahchan, et alGenomic analysis of fibrolamellar hepatocellular carcinoma
857/2014Case reportSulaiman, GeberhiwotFibrolamellar Hepatocellular Carcinoma Mimicking Ornithine Transcarbamylase Deficiency
847/2014Case reportFonseca, Varella, Coelho, Abe, et alDownstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma
836/2014SignallingRiehle, Yeh, Yu, Kenerson, et almTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma
826/2014SEER studyEggert, McGlynn, Duffy, Manns, et alFibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results databas
816/2014Case reportChiarelli, De Simone, Guttadauro, CioffiFibrolamellar carcinoma in a 62 year-old patient with human immunodeficiency virus infection
806/2014DiagnosticsDo, McErlean, Ang, et alCT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients
795/2014ReviewGroeschl, Miura, Wong, Bloomston, et alMulti‐institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma
783/2014Case reportOkur, Eser, Yilmaz, Dalgic, et alSuccessful Multimodal Treatment for Aggressive Metastatic and Recurrent Fibrolamellar Hepatocellular Carcinoma in a Child
772/2014GenomicsHoneyman, Simon, Robine, Clarke, et alDetection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
762/2014DiagnosticsGaneshan, Szklaruk, Kundra, Kaseb, et alImaging Features of Fibrolamellar Hepatocellular Carcinoma
751/2014GenomicsMalouf, Job, Paradis, Fabre, et alTranscriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature
741/2014SEER studyBasileLong-term Survival of Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A US Population-based Study
731/2014ReviewAllan, Wang, Davis, et alA review of 218 pediatric cases of hepatocellular carcinoma
7212/2013ReviewMayo, Mavros, Nathan, et alTreatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective
7111/2013Case reportPeacock, Call, OlivierRadiotherapy for metastatic fibrolamellar hepatocellular carcinoma
709/2013ReviewKaseb, Sharma, Sahin, Nooka, et alTreatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma
698/2013Case reportMinutolo, Licciardello, Arena, Minutolo, et alSurgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
687/2013Case reportDe Gaetano, Nure, Grossi, Frongillo, et alFibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association
677/2013Case reportMatsuda, Amemiya, Kawaida, Okamoto, et alTypical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case
667/2013ReviewKaseb, Sharma, Sahin, Nooka, et alPrognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma
655/2013EpidemiologyEggert, McGlynn, Duffy, Manns, et alEpidemiology of fibrolamellar hepatocellular carcinoma in the U.S., 2000–2010
645/2013ReviewWeeda, Murawski, McCabe, et alFibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
635/2013Case reportFakihA Case of Fibrolamellar Cancer With a Palliative Response and Minor Radiographic Regression With Erlotinib and Bevacizumab Combination Therapy
623/2013ReviewAng, Kelley, Choti, Cosgrove, et alClinicopathologic Characteristics and Survival Outcomes of Patients With Fibrolamellar Carcinoma: Data From the Fibrolamellar Carcinoma Consortiu
611/2013Case reportSingh, RamakrishnaCombined Hepatocellular Carcinoma and Fibrolamellar Carcinoma Presenting as Two Adjacent Separate Lesions in a Young Boy: First Case Report from Asia
6010/2012Case reportBerger, Dimant, Hermida, Paulin, et alHyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma
599/2012ReviewMavros, Mayo, Hyder, et alA Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
588/2012GenomicsPatonai, Erdelyi-Belle, Korompay, et alMolecular Characteristics of Fibrolamellar Hepatocellular Carcinoma
573/2012Case reportGras, Truant, Boige, Ladrat, et al Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
563/2012Case reportKnudson, Goldberg, AyresFibrolamellar hepatocellular carcinoma with cardiac spread causing severe inferior vena cava obstruction in a 9-year-old child
553/2012ReviewMalouf, Brugieres, Le Deley, Faivre, et alPure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection
542/2012Case reportBenito, Segura, Martinez. et alFibrolamellar hepatocellular carcinoma metastatic to the ovary
531/2012Case reportKo, Verhoeven, Lee, Corbin, Vogl and PedersenA Translational Study "Case Report" on the Small Molecule "Energy Blocker" 3Bromopyruvate (3BP) as a Potent Anticancer Agent: From Bench Side to Bedside
521/2012Mechanisms, pathwaysWilczek, Szparecki, Lukasik, KoperskiLoss of the Orphan Nuclear Receptor SHP Is More Pronounced in Fibrolamellar Carcinoma than in Typical Hepatocellular Carcinom
511/2012ReviewTorbensonFibrolamellarCarcinoma:2012Update
505/2011Case reportMuramori, Taguchi, Taguchi, Kohashi, et alHigh Aromatase Activity and Overexpression of Epidermal Growth Factor Receptor in Fibrolamellar Hepatocellular Carcinoma in a Child
494/2011MarkersPatonai, Erdelyi-Belle, Korompay, Somoracz, et alClaudins and tricellulin in fibrolamellar hepatocellular carcinoma
484/2011Case reportLiu, Chan, Tong, Wang, et alPET–CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature
472/2011ReviewWard, WaxmanFibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors
4612/2010ReviewDhingra, Li, Tan, Zenali, et alCell cycle biology of fibrolamellar hepatocellular carcinoma
4511/2010GenomicsRoss, Daniel, Vivekanandan, Kannangai, et alFibrolamellar Carcinomas are Positive for CD68
4411/2010MarkersLidballe, Nguyen, Poulsen, et alHaptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
4311/2010GenomicsTrankenschuh, Puls, Christgen, Albat, et alFrequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver
425/2010ReviewWard, Huang, Tickoo, ThungFibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
415/2010ComparativeAbdul-Al, Wang, MahkloufFibrolamellar Hepatocellular Carcinoma: An Immunohistochemical Comparison With Conventional Hepatocellular Carcinoma
404/2010ComparativeZenali, Tan, Li, Dhingra, BrownStemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma
393/2010Genomics Vivekanandan, Daniel, Yeh, TorbensonMitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
383/2010Mechanisms, pathwaysLi, Tan, Zenali, BrownConstitutive activation of nuclear factor-kappa B (NF-κB) signaling pathway in fibrolamellar hepatocellular carcinom
372/2010Case reportBhanjee, Locketz, KrigeFibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series
3612/2009Case reportSethi, Tageja, Dave, et alHyperammonemic Encephalopathy: A Rare Presentation of Fibrolamellar Hepatocellular Carcinoma
3512/2009Case reportTerzis, Haritanti, EconomouFibrolamellar Hepatocellular Carcinoma: a Case Report with Distinct Radiological Feature
347/2009ReviewLiu, Chan, Wang, QiaoFibrolamellar hepatocellular carcinoma
337/2009Case reportButte, Waugh, Meneses, Pruzzo, et alFibrolamellar liver carcinoma: report of two cases and review of the literature
3111/2008GenomicsKakar, Chen, Ho, Burgart, et alChromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization
3011/2008Genomics Vivekanandan, Shien, TorensonAnterior Gradient-2 is Over Expressed by Fibrolamellar Carcinomas
293/2008Case reportSmith, Blatt, Jedicka, Strain, FentonFibrolamellar Hepatocellular Carcinoma
282/2008GenomicsVivekanandan, TorensonEpigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas
275/2007Case reportMeriggi, ForniSurgical therapy of hepatic fibrolamellar carcinoma
264/2007ReviewTorbensonReview of the Clinicopathologic Features of Fibrolamellar Carcinoma
253/2007GenomicsKannangai, Vivekanandan, Martinez-Murillo, Choti, et alFibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways
2410/2005Case reportImkie, Myers, Li, Fan, et alFibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases
2310/2005Case reportZermani, Charfi, Kourda, Farah, et alA particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant
229/2005PathologyKlein, Molmenti, Colombani, Grover, et alPrimary Liver Carcinoma Arising in People Younger Than 30 Years
205/2005PathologyKakar, Burgart, Batts, Gacia, et alClinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis
1912/2004Mechanisms, pathwaysSahin, Kannangai, Adegbola, Wang, et almTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms
188/2004Case reportKanai, Takabayashi, Kawano, et alA Case of Postoperative Recurrence of Fibrolamellar Hepatocellular Carcinoma with Increased Vitamin B12 Binding Capacity in a Young Japanese Female
173/2004DiagnosticsVasdev, NayakCD99 expression in hepatocellular carcinoma: an immunohistochemical study in the fibrolamellar and common variant of the tumour
163/2004SEER studyEl-Serag, DavilaIs fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study
151/2004Case reportTerracciano, Tornilla, Avoledo, et alFibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis
1412/2003Case reportKitabayashi, Yokoi, Ueno, Saito, et alFibrolamellar hepatocellular carcinoma: report of a case
134/2003ReviewKatzenstein, Krailo, Malogolowkin, Ortega, et alFibrolamellar hepatocellular carcinoma in children and adolescents
112/2003Clinical trialPatt, Hassan, Lozano, Brown, et alPhase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma
1011/2002GuidelinesRyderGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
98/2002ReviewArista-Nasr, Gutierrez-Villalobos, Nuncio, Maldonato, et alFibrolamellar hepatocellular carcinoma in mexican patients
81/2002DiagnosticsWang, Cui, YuImaging findings of fibrolamellar hepatocellular carcinoma
76/2001GenomicsSirivatanauksorn, Sirivatanauksorn, Lemoine, Williamson, DavidsonGenomic homogeneity in fibrolamellar carcinomas
65/2001Case reportBraune, Frangmann, Scheumann, KlempnauerMultiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient
55/2001GenomicsWilkins, Bredt, Flemming, Kubicka, et alCytogenetic Aberrations in Primary and Recurrent Fibrolamellar Hepatocellular Carcinoma Detected by Comparative Genomic Hybridization
412/2000ReviewEl-Gazzaz, Wong, El-Hadary, Gunson, et alOutcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma
39/2000DiagnosticsIchikawa, Federle, Grazioli, MarshFibrolamellar Hepatocellular Carcinoma: Pre- and Posttherapy Evaluation with CT and MR Imaging
27/1988Case reportBerman, Burnhamet and SheahanFibrolamellar carcinoma of the liver: An immunohistochemical study of nineteen cases and a review of the literature
18/1982MarkerParadinas, Melia, Wilkinson, Portmann et al.High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma